| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Renal Physiology, Vol 261, Issue 4 578-F586, Copyright © 1991 by American Physiological Society
ARTICLES |
T. Katoh, K. Takahashi, J. Capdevila, A. Karara, J. R. Falck, H. R. Jacobson and K. F. Badr
Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232.
Renal glomerular and cortical metabolism of endogenous arachidonic acid by cytochrome P-450 epoxygenase yields 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acids (EET). Using gas chromatography-mass spectrometry, we measured the synthesis of 8,9-EET from an endogenous pool of arachidonic acid in normal rat kidney. The (8S,9R) isomer was favored over the (8R,9S) isomer in a ratio (%) of 59 to 41 in isolated glomeruli and 68 to 32 in cortex tissue. (8S,9R)- but not (8R,9S)-EET elicited dose-dependent vasoconstriction on intrarenal administration in the euvolemic Munich-Wistar rat. Micropuncture measurements of glomerular dynamics revealed that (8S,9R)-EET increased afferent arteriolar resistance (RA) leading to reductions in single-nephron plasma flow rate (QA), net transcapillary hydraulic pressure difference (delta P), and consequently single-nephron glomerular filtration rate (SNGFR). There was no significant change in the value of the glomerular capillary ultrafiltration coefficient (Kf). In the presence of a cyclooxygenase inhibitor, indomethacin, the effects of 8,9-EET were reversed. RA fell leading to increases in QA and delta P, with resultant augmentation of SNGFR. Under these conditions, a modest reduction if Kf was noted. Thus (8S,9R)-EET is a stereoselective renal vasoconstrictor, preferentially generated over its optical isomer, (8R,9S)-EET, suggesting that it is biologically relevant and implying specific structural requirements for EET receptor activation. The principal mechanism of action of 8,9-EET is preglomerular vasoconstriction. The vasoconstrictor effect of 8,9-EET is CO dependent.
This article has been cited by other articles:
|
|
 |
|
  W. B. Campbell, B. B. Holmes, J. R. Falck, J. H. Capdevila, and K. M. Gauthier Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H64 - H71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yu, B. B. Davis, C. Morisseau, B. D. Hammock, J. L. Olson, D. L. Kroetz, and R. H. Weiss Vascular localization of soluble epoxide hydrolase in the human kidney Am J Physiol Renal Physiol, April 1, 2004; 286(4): F720 - F726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. O. Ogungbade, L. A. Akinsanmi, H. Jiang, and A. O. Oyekan Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat Am J Physiol Renal Physiol, November 1, 2003; 285(5): F955 - F964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lu, M. VanRollins, and H.-C. Lee Stereospecific Activation of Cardiac ATP-Sensitive K+ Channels by Epoxyeicosatrienoic Acids: A Structural Determinant Study Mol. Pharmacol., November 1, 2002; 62(5): 1076 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Wang, Y. Yang, M. F. Sullivan, J. Min, J. Cai, D. C. Zeldin, Y.-F. Xiao, and J. P. Morgan Induction of Cardiac Cytochrome P450 in Cocaine-Treated Mice Experimental Biology and Medicine, March 1, 2002; 227(3): 182 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, C. L. Oltman, T. Lu, H.-C. Lee, K. C. Dellsperger, and M. VanRollins EET homologs potently dilate coronary microvessels and activate BKCa channels Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2430 - H2440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Benoit, B. Renaudon, D. Salvail, and E. Rousseau EETs relax airway smooth muscle via an EpDHF effect: BKCa channel activation and hyperpolarization Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L965 - L973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yu, F. Xu, L. M. Huse, C. Morisseau, A. J. Draper, J. W. Newman, C. Parker, L. Graham, M. M. Engler, B. D. Hammock, et al. Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids Circ. Res., November 24, 2000; 87(11): 992 - 998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Yu, L. M. Huse, P. Adler, L. Graham, J. Ma, D. C. Zeldin, and D. L. Kroetz Increased CYP2J Expression and Epoxyeicosatrienoic Acid Formation in Spontaneously Hypertensive Rat Kidney Mol. Pharmacol., May 1, 2000; 57(5): 1011 - 1020. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. H. Capdevila, J. R. Falck, and R. C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase J. Lipid Res., February 1, 2000; 41(2): 163 - 181. [Abstract] [Full Text]
|
|
|
|
 |
|
 X. Fang, N. L. Weintraub, L. L. Stoll, and A. A. Spector Epoxyeicosatrienoic Acids Increase Intracellular Calcium Concentration in Vascular Smooth Muscle Cells Hypertension, December 1, 1999; 34(6): 1242 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ma, W. Qu, P. E. Scarborough, K. B. Tomer, C. R. Moomaw, R. Maronpot, L. S. Davis, M. D. Breyer, and D. C. Zeldin Molecular Cloning, Enzymatic Characterization, Developmental Expression, and Cellular Localization of a Mouse Cytochrome P450 Highly Expressed in Kidney J. Biol. Chem., June 18, 1999; 274(25): 17777 - 17788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Ito and R. J. Roman Regulation of P-450 4A activity in the glomerulus of the rat Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1749 - R1757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-K. Chen, D.-W. Wang, J. R. Falck, J. Capdevila, and a. R. C. Harris Transfection of an Active Cytochrome P450 Arachidonic Acid Epoxygenase Indicates That 14,15-Epoxyeicosatrienoic Acid Functions as an Intracellular Second Messenger in Response to Epidermal Growth Factor J. Biol. Chem., February 19, 1999; 274(8): 4764 - 4769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Imig, E. W. Inscho, P. C. Deichmann, K. M. Reddy, and J. R. Falck Afferent Arteriolar Vasodilation to the Sulfonimide Analog of 11,12-Epoxyeicosatrienoic Acid Involves Protein Kinase A Hypertension, January 1, 1999; 33(1): 408 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dumoulin, D. Salvail, S. B. Gaudreault, A. Cadieux, and E. Rousseau Epoxyeicosatrienoic acids relax airway smooth muscles and directly activate reconstituted KCa channels Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L423 - L431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. S. Pascual, A. McKenzie, J. R. Yankaskas, J. R. Falck, and D. C. Zeldin Epoxygenase Metabolites of Arachidonic Acid Affect Electrophysiologic Properties of Rat Tracheal Epithelial Cells1 J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 772 - 779. [Abstract] [Full Text]
|
|
|
|
|
|
M.-H. Wang, E. Brand-Schieber, B. A. Zand, X. Nguyen, J. R. Falck, N. Balu, and M. L. Schwartzman Cytochrome P450-Derived Arachidonic Acid Metabolism in the Rat Kidney: Characterization of Selective Inhibitors J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 966 - 973. [Abstract] [Full Text]
|
|
|
|
|
|
D. C. Zeldin, J. Foley, S. M. Goldsworthy, M. E. Cook, J. E. Boyle, J. Ma, C. R. Moomaw, K. B. Tomer, C. Steenbergen, and S. Wu CYP2J Subfamily Cytochrome P450s in the Gastrointestinal Tract: Expression, Localization, and Potential Functional Significance Mol. Pharmacol., June 1, 1997; 51(6): 931 - 943. [Abstract] [Full Text]
|
|
|
|
|
|
S. Wu, W. Chen, E. Murphy, S. Gabel, K. B. Tomer, J. Foley, C. Steenbergen, J. R. Falck, C. R. Moomaw, and D. C. Zeldin Molecular Cloning, Expression, and Functional Significance of a Cytochrome P450 Highly Expressed in Rat Heart Myocytes J. Biol. Chem., May 9, 1997; 272(19): 12551 - 12559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Fang, T. L. Kaduce, N. L. Weintraub, M. VanRollins, and A. A. Spector Functional Implications of a Newly Characterized Pathway of 11,12-Epoxyeicosatrienoic Acid Metabolism in Arterial Smooth Muscle Circ. Res., October 1, 1996; 79(4): 784 - 793. [Abstract] [Full Text]
|
|
|
|
|
|
J. H. Capdevila, S. Wei, C. Helvig, J. R. Falck, Y. Belosludtsev, G. Truan, S. E. Graham-Lorence, and J. A. Peterson The Highly Stereoselective Oxidation of Polyunsaturated Fatty Acids by Cytochrome P450BM-3 J. Biol. Chem., September 13, 1996; 271(37): 22663 - 22671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Sinal, M. Miyata, M. Tohkin, K. Nagata, J. R. Bend, and F. J. Gonzalez Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation J. Biol. Chem., December 15, 2000; 275(51): 40504 - 40510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Zeldin Epoxygenase Pathways of Arachidonic Acid Metabolism J. Biol. Chem., September 21, 2001; 276(39): 36059 - 36062. [Full Text] [PDF]
|
|
|
|
 |
|
 B. B. Davis, D. A. Thompson, L. L. Howard, C. Morisseau, B. D. Hammock, and R. H. Weiss Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation PNAS, February 19, 2002; 99(4): 2222 - 2227. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
